%0 Journal Article
%A Salwender, Hans
%A Elmaagacli, Ahmet
%A Merz, Maximilian
%A Miah, Kaya
%A Benner, Axel
%A Haenel, Mathias
%A Jehn, Christian
%A Mai, Elias K
%A Bertsch, Uta
%A Blau, Igor W
%A Scheid, Christof
%A Hose, Dirk
%A Seckinger, Anja
%A Jauch, Anna
%A Raab, Marc S
%A Luntz, Steffen P
%A Besemer, Britta
%A Munder, Markus
%A Brossart, Peter
%A Fuhrmann, Stephan
%A Lindemann, Hans-Walter
%A Weisel, Katja
%A Duerig, Jan
%A Goldschmidt, Hartmut
%T Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial.
%J Leukemia
%V 35
%N 10
%@ 1476-5551
%C London
%I Springer Nature
%M DKFZ-2021-01159
%P 3007-3011
%D 2021
%Z 2021 Oct;35(10):3007-3011
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:34031532
%R 10.1038/s41375-021-01298-y
%U https://inrepo02.dkfz.de/record/168957